| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.29 | 0.02 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |